Atria Investments Inc Has $7.69 Million Position in Colgate-Palmolive (NYSE:CL)

Atria Investments Inc reduced its position in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 7.2% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 74,065 shares of the company's stock after selling 5,737 shares during the period. Atria Investments Inc's holdings in Colgate-Palmolive were worth $7,689,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the company. E Fund Management Hong Kong Co. Ltd. purchased a new stake in Colgate-Palmolive in the second quarter valued at $25,000. Continuum Advisory LLC lifted its position in Colgate-Palmolive by 46.5% in the second quarter. Continuum Advisory LLC now owns 394 shares of the company's stock valued at $38,000 after acquiring an additional 125 shares during the last quarter. Reston Wealth Management LLC purchased a new stake in Colgate-Palmolive in the third quarter valued at $42,000. Capital Performance Advisors LLP purchased a new stake in Colgate-Palmolive in the third quarter valued at $53,000. Finally, Gradient Investments LLC lifted its position in Colgate-Palmolive by 150.4% in the second quarter. Gradient Investments LLC now owns 666 shares of the company's stock valued at $65,000 after acquiring an additional 400 shares during the last quarter. 80.41% of the stock is owned by hedge funds and other institutional investors.

Colgate-Palmolive Stock Down 0.5 %

NYSE CL traded down $0.45 during trading hours on Tuesday, reaching $91.51. 4,927,123 shares of the company traded hands, compared to its average volume of 4,377,176. The company has a 50 day moving average of $100.62 and a two-hundred day moving average of $98.52. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a 12 month low of $75.17 and a 12 month high of $109.30. The stock has a market capitalization of $74.76 billion, a PE ratio of 26.36, a PEG ratio of 3.31 and a beta of 0.42.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be given a $0.50 dividend. The ex-dividend date is Friday, October 18th. This represents a $2.00 annualized dividend and a yield of 2.19%. Colgate-Palmolive's dividend payout ratio is presently 57.31%.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the stock. Redburn Atlantic upgraded shares of Colgate-Palmolive to a "hold" rating in a research note on Thursday, August 1st. TD Cowen dropped their price target on shares of Colgate-Palmolive from $115.00 to $110.00 and set a "buy" rating on the stock in a research note on Monday, October 28th. Wells Fargo & Company lowered their target price on shares of Colgate-Palmolive from $100.00 to $92.00 and set an "underweight" rating on the stock in a research report on Monday, October 28th. Evercore ISI upped their target price on shares of Colgate-Palmolive from $100.00 to $106.00 and gave the stock an "outperform" rating in a research report on Thursday, July 18th. Finally, Sanford C. Bernstein upped their target price on shares of Colgate-Palmolive from $100.00 to $103.00 and gave the stock a "market perform" rating in a research report on Tuesday, July 30th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $105.11.

Insider Activity at Colgate-Palmolive

In related news, Director Martina Hundmejean sold 2,313 shares of Colgate-Palmolive stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $103.86, for a total value of $240,228.18. Following the sale, the director now directly owns 11,755 shares in the company, valued at $1,220,874.30. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In other news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares of the company's stock, valued at $3,456,283.86. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Martina Hundmejean sold 2,313 shares of the firm's stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the transaction, the director now owns 11,755 shares of the company's stock, valued at approximately $1,220,874.30. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.34% of the stock is currently owned by insiders.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.